A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
The objective of the study was to compare the efficacy of 0.4mg Tamsulosin and 8mg Silodosin once daily dosing in patients with Benign Prostatic Hyperplasia (BPH) treated for 4 weeks. A Prospective Observational study which included 91 men who all were newly diagnosed with Benign Prostatic Hyperplasia. Maximum Urinary flow Rate (Qmax), Voided Volume were measured as Uroflowmetric parameters for assessment at the beginning and after 1 month of therapy. International Prostate Symptom Score anddoi:10.5281/zenodo.3265344 fatcat:jmiehtzy7nayle2boifd7l2s6q